CLINICAL RESEARCH: PROGNOSTICATORS IN ACUTE INFARCTION
Long-Term Prognostic Value of ST-Segment Resolution in Patients Treated With Fibrinolysis or Primary Percutaneous Coronary InterventionResults From the DANAMI-2 (DANish trial in Acute Myocardial Infarction-2)
Maria Sejersten, MD*,*,
Nana Valeur, MD, PhD*,
Peer Grande, MD, DMSc*,
Torsten Toftegaard Nielsen, MD, DMSc ,
Peter Clemmensen, MD, DMSc* for the DANAMI-2 Investigators
* Heart Center, Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Faculty of Health Sciences, Copenhagen, Denmark
Department of Cardiology, Skejby University Hospital, Aarhus, Denmark
Manuscript received November 3, 2008;
revised manuscript received March 19, 2009,
accepted March 24, 2009.
* Reprint requests and correspondence: Dr. Maria Sejersten, Department of Cardiology B, 2142, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark (Email: msejersten{at}hotmail.com).
Objectives: The purpose of this study was to determine the prognostic value of ST-segment resolution after primary percutaneous coronary intervention (pPCI) versus fibrinolysis.
Background: Resolution of the ST-segment has been used as a surrogate end point in trials evaluating reperfusion in acute myocardial infarction; however, its prognostic significance may be limited to patients treated with fibrinolysis.
Methods: In the DANAMI-2 (DANish trial in Acute Myocardial Infarction-2) substudy, including 1,421 patients, the ST-segment elevation at baseline, pre-intervention, 90 min, and 4 h was assessed. The ST-segment resolution was grouped as follows: 1) complete 70%; 2) partial 30% to <70%; and 3) no resolution <30%. End points were 30-day and long-term mortality and reinfarction.
Results: The ST-segment resolution at 90 min was more pronounced after pPCI (median 60% vs. 45%, p < 0.0001), and a catch-up phenomenon was observed at 4 h. In the fibrinolysis group, 30-day and long-term mortality rates were significantly higher among patients without ST-segment resolution, whereas reinfarction rates were higher with complete ST-segment resolution. The ST-segment resolution was not associated with the 2 end points in the pPCI group. By multivariate analysis, ST-segment resolution at 4 h was an independent predictor of lower mortality, but higher reinfarction rates among patients receiving fibrinolytic therapy.
Conclusions: The ST-segment resolution at 90 min was more complete after pPCI, suggesting better epicardial and microvascular reperfusion, whereas no difference between treatment strategies was seen at 4 h. The ST-segment resolution at 4 h correlated with decreased mortality, but increased reinfarction rates among patients receiving fibrinolytic therapy, whereas no association was seen for patients receiving pPCI. Consequently, 4-h ST-segment resolution remains an important prognosticator after fibrinolysis, but may be overemphasized as a surrogate end point after pPCI.
Key Words: primary percutaneous coronary intervention fibrinolysis ST-segment elevation myocardial infarction ST-segment resolution outcome
|
Abbreviations and Acronyms
| | ECG = electrocardiogram | | IQR = interquartile range | | PCI = percutaneous coronary intervention | | pPCI = primary percutaneous coronary intervention | | STEMI = ST-segment elevation myocardial infarction | ST = sum of ST-segment elevation |
|
Related Articles
-
ST-Segment Resolution and Outcome in Myocardial Infarction
- Christopher E. Buller, Cynthia M. Westerhout, and Paul W. Armstrong
J. Am. Coll. Cardiol. 2010 55: 1646-1647.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A40.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. B. Kahn, R. M. Cubbon, B. Mercer, A. C. Wheatcroft, G. Gherardi, A. Aziz, V. Baliga, J. M. Blaxill, J. M. McLenachan, D. J. Blackman, et al.
Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era
Diabetes and Vascular Disease Research,
January 1, 2012;
9(1):
3 - 9.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Martinoni, S. D. Servi, E. Boschetti, R. Zanini, T. Palmerini, A. Politi, G. Musumeci, G. Belli, M. D. Paolis, F. Ettori, et al.
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty
European Journal of Cardiovascular Prevention & Rehabilitation,
June 1, 2011;
18(3):
526 - 532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fresco
Letter by Fresco Regarding Article "Primary Angioplasty Versus Fibrinolysis in Acute Myocardial Infarction: Long-Term Follow-Up in the Danish Acute Myocardial Infarction 2 Trial"
Circulation,
December 21, 2010;
122(25):
e640 - e640.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. L. Gu, M. A. Kampinga, W. G. Wieringa, M. L. Fokkema, M. W. Nijsten, H. L. Hillege, A. F. M. van den Heuvel, E.-S. Tan, G. Pundziute, R. van der Werf, et al.
Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration: The Comparison of Intracoronary Versus Intravenous Abciximab Administration During Emergency Reperfusion of ST-Segment Elevation Myocardial Infarction (CICERO) Trial
Circulation,
December 21, 2010;
122(25):
2709 - 2717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Kober, J. E. Moller, and C. Torp-Pedersen
Moderate Pericardial Effusion Early After Myocardial Infarction: Left Ventricular Free Wall Rupture Until Proven Otherwise
Circulation,
November 9, 2010;
122(19):
1898 - 1899.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sejersten and P. Clemmensen
Reply
J. Am. Coll. Cardiol.,
April 13, 2010;
55(15):
1647 - 1647.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Buller, C. M. Westerhout, and P. W. Armstrong
ST-Segment Resolution and Outcome in Myocardial Infarction
J. Am. Coll. Cardiol.,
April 13, 2010;
55(15):
1646 - 1647.
[Full Text]
[PDF]
|
 |
|
|